Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Sub: Allotment of shares under Strides ESOP 2016 Plan This has reference to the intimation made to BSE Limited today in relation to the allotment of 54,700 shares under Strides ESOP 2016 Plan. Further, kindly note, the approval was sought from the Management Committee of the Board of Directors of the Company in its meeting held today. However, you may please note that in the prior intimation made today, it was erroneously mentioned as approval sought in the 'Board of Directors meeting' instead of 'Management Committee Meeting'. Request you to please consider the revised intimation which is enclosed along with this letter and consider the same in your records.
06-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Allotment of shares under Strides ESOP 2016 Plan The Board of Directors of the Company in their meeting held today have allotted 54,700 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan. These shares shall rank in pari passu with the existing equity shares of the Company in all respects. Consequent to above, the paid-up share capital of the Company has increased from Rs. 89,72,27,140/- consisting of 8,97,22,714 equity shares of Rs. 10/- each to Rs. 89,77,74,140/- consisting of 8,97,77,414 equity shares of Rs. 10/- each.
06-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 We wish to inform you that the 30th Annual General Meeting ('AGM') of the Company was held on Friday, September 3, 2021. All the items of the business as mentioned in the AGM Notice dated May 27, 2021, have been transacted and all the resolutions have been passed by the Members with requisite majority by way of remote e-voting and e-voting at the meeting. In this connection, please find enclosed the following: a) Voting Results as required under Regulation 44 of SEBI Listing Regulations as Annexure 1. b) Report of Scrutinizer dated September 4, 2021 pursuant to the Companies Act, 2013 and Rules made thereunder as Annexure 2. This is for your information and records.
04-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 We wish to inform you that the 30th AGM of the Company was held on Friday, September 3, 2021 through Video Conference. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the summary of proceedings of the AGM. This is for your information and records.
03-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding request received for issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 SURIYA PRAKASH P
03-09-2021
Bigul

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 Grant of Options under Strides ESOP Plan 2016
31-08-2021
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 31, 2021 for Pronomz Ventures LLP
31-08-2021
Bigul

Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding Issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Bhagavandas Giradharlal/ Kantaben Bhagavandas
20-08-2021
Bigul

Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 18, 2021 for Pronomz Ventures LLP
18-08-2021
Next Page
Close

Let's Open Free Demat Account